|
Real-time Estimate
Tradegate
01:12:50 09/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 3.160 EUR | -1.68% |
|
-0.13% | -42.28% |
| 02/09 | Evotec, Plectonic Launch Research Collaboration on New T-Cell Approaches for Solid Tumors | MT |
| 02/09 | Evotec, Plectonic Biotech Partner on Research of Novel Immunotherapy for Solid Tumors | MT |
| Market Cap | 571M 664M 537M 490M 917M 62.82B 920M 6.37B 2.46B 32.17B 2.49B 2.44B 102B | P/E 2026 * |
-2.74x | P/E 2027 * | -7.47x |
|---|---|---|---|---|---|
| Enterprise Value | 714M 830M 672M 613M 1.15B 78.53B 1.15B 7.96B 3.08B 40.22B 3.12B 3.05B 128B | EV / Sales 2026 * |
1.19x | EV / Sales 2027 * | 1.01x |
| Free-Float |
89.91% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Xetra
| EVT | Delayed | |
Tradegate
| EVT | Real-time | |
|
CBOE
| EVTd | Real-time | |
|
Boerse Muenchen
| EVT | Real-time | |
|
Börse Stuttgart
| EVT | Delayed | |
|
Borsa Italiana
| 1EVT | End-of-day quote | |
|
Deutsche Boerse AG
| EVT | Delayed | |
|
CBOE
| 0IRF | Real-time | |
|
Bulgaria S.E.
| EVT | End-of-day quote | |
|
OTC Markets
| EVOTF | Delayed | |
|
Wiener Boerse
| EVT | End-of-day quote | |
|
London S.E.
| 0IRF | Delayed | |
|
Swiss Exchange
| EVT | Delayed |
Last Transcript : Evotec SE
| 1 day | -2.05% | ||
| 1 week | +0.57% | ||
| Current month | -2.40% | ||
| 1 month | -13.35% | ||
| 3 months | -35.77% | ||
| 6 months | -39.89% | ||
| Current year | -41.87% |
| 1 week | 3.12 |  | 3.37 |
| 1 month | 3.12 | | 3.88 |
| Current year | 3.12 | | 6.73 |
| 1 year | 3.12 | | 7.3 |
| 3 years | 3.12 | | 23.44 |
| 5 years | 3.12 | | 45.83 |
| 10 years | 3.12 | | 45.83 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 01/07/2024 | |
| Director of Finance/CFO | - | 01/05/2026 | |
Ingrid Müller
COO | Chief Operating Officer | - | 01/05/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Roland Sackers
BRD | Director/Board Member | 58 | 19/06/2019 |
| Director/Board Member | 64 | 01/06/2021 | |
Duncan McHale
BRD | Director/Board Member | 59 | 10/06/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/5/26 | Exercice | Chief Technology Officer | 12,462 | 0.0070% | ||
| 4/5/26 | Buy | 15,510 | 0.0087% | |||
| 4/5/26 | Buy | Head of Human Resources | 15,228 | 0.0086% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.08% | +0.57% | -46.03% | -85.12% | 664M | |
| -0.43% | -3.12% | -1.82% | +15.71% | 48.41B | |
| +0.04% | +1.12% | +416.85% | +560.71% | 45.01B | |
| -2.05% | +1.58% | +39.83% | +22.90% | 44.07B | |
| -3.58% | -3.14% | +0.27% | +80.34% | 40.73B | |
| -0.96% | -1.38% | +15.75% | +45.91% | 33.21B | |
| -0.95% | +4.16% | - | - | 17.77B | |
| +0.20% | +1.67% | +20.50% | +118.72% | 16.5B | |
| -0.34% | -0.34% | +11.58% | +31.64% | 14.45B | |
| -2.29% | +0.28% | +74.77% | +41.74% | 13.77B | |
| Average | -1.25% | +0.16% | +59.08% | +92.51% | 27.46B | |
| Weighted average by Cap. | -1.23% | -0.03% | +87.49% | +135.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 601M 699M 565M 516M 965M 66.08B 968M 6.7B 2.59B 33.84B 2.62B 2.57B 108B | 724M 842M 681M 622M 1.16B 79.63B 1.17B 8.08B 3.12B 40.78B 3.16B 3.09B 130B |
| Net income | -202M -235M -190M -173M -324M -22.21B -325M -2.25B -871M -11.38B -882M -863M -36.23B | -48.25M -56.1M -45.38M -41.43M -77.48M -5.31B -77.73M -538M -208M -2.72B -211M -206M -8.66B |
| Net Debt | 143M 166M 134M 123M 229M 15.71B 230M 1.59B 616M 8.04B 624M 610M 25.62B | 162M 189M 153M 139M 260M 17.83B 261M 1.81B 699M 9.13B 708M 693M 29.09B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/09/26 | EUR 3.146 | -2.12% | 587,932 |
| 07/09/26 | EUR 3.214 | +0.06% | 254,080 |
| 04/09/26 | EUR 3.212 | -1.89% | 1,086,118 |
| 03/09/26 | EUR 3.274 | -0.97% | 485,055 |
| 02/09/26 | EUR 3.306 | +4.95% | 906,734 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EVT Stock
Select your edition
All financial news and data tailored to specific country editions
